Nardone Raffaele, Höller Yvonne, Brigo Francesco, Orioli Andrea, Tezzon Frediano, Schwenker Kerstin, Christova Monica, Golaszewski Stefan, Trinka Eugen
Department of Neurology, Christian Doppler Klinik, Paracelsus Medical University and Center for Cognitive Neuroscience, Salzburg, Austria; Department of Neurology, Franz Tappeiner Hospital, Merano, Via Rossini 5, 39012 Meran/o (BZ), Italy; Spinal Cord Injury and Tissue Regeneration Center, Paracelsus Medical University, Salzburg, Austria.
Department of Neurology, Christian Doppler Klinik, Paracelsus Medical University and Center for Cognitive Neuroscience, Salzburg, Austria; Spinal Cord Injury and Tissue Regeneration Center, Paracelsus Medical University, Salzburg, Austria.
Brain Res. 2015 Sep 4;1619:139-54. doi: 10.1016/j.brainres.2014.09.036. Epub 2014 Sep 22.
We performed here a systematic review of the studies using transcranial magnetic stimulation (TMS) as a research and clinical tool in patients with spinal cord injury (SCI). Motor evoked potentials (MEPs) elicited by TMS represent a highly accurate diagnostic test that can supplement clinical examination and neuroimaging findings in the assessment of SCI functional level. MEPs allows to monitor the changes in motor function and evaluate the effects of the different therapeutic approaches. Moreover, TMS represents a useful non-invasive approach for studying cortical physiology, and may be helpful in elucidating the pathophysiological mechanisms of brain reorganization after SCI. Measures of motor cortex reactivity, e.g., the short interval intracortical inhibition and the cortical silent period, seem to point to an increased cortical excitability. However, the results of TMS studies are sometimes contradictory or divergent, and should be replicated in a larger sample of subjects. Understanding the functional changes at brain level and defining their effects on clinical outcome is of crucial importance for development of evidence-based rehabilitation therapy. TMS techniques may help in identifying neurophysiological biomarkers that can reliably assess the extent of neural damage, elucidate the mechanisms of neural repair, predict clinical outcome, and identify therapeutic targets. Some researchers have begun to therapeutically use repetitive TMS (rTMS) in patients with SCI. Initial studies revealed that rTMS can induce acute and short duration beneficial effects especially on spasticity and neuropathic pain, but the evidence is to date still very preliminary and well-designed clinical trials are warranted. This article is part of a Special Issue entitled SI: Spinal cord injury.
我们对将经颅磁刺激(TMS)作为脊髓损伤(SCI)患者研究及临床工具的相关研究进行了系统综述。TMS诱发的运动诱发电位(MEP)是一项高度准确的诊断测试,在评估SCI功能水平时可补充临床检查及神经影像学检查结果。MEP能够监测运动功能变化,并评估不同治疗方法的效果。此外,TMS是研究皮质生理学的一种有用的非侵入性方法,可能有助于阐明SCI后脑重组的病理生理机制。运动皮质反应性的测量指标,如短间隔皮质内抑制和皮质静息期,似乎表明皮质兴奋性增加。然而,TMS研究结果有时相互矛盾或存在分歧,应在更大样本的受试者中进行重复验证。了解脑水平的功能变化并确定其对临床结局的影响对于循证康复治疗的发展至关重要。TMS技术可能有助于识别神经生理学生物标志物,这些标志物能够可靠地评估神经损伤程度、阐明神经修复机制、预测临床结局并确定治疗靶点。一些研究人员已开始对SCI患者进行重复经颅磁刺激(rTMS)治疗。初步研究表明,rTMS尤其对痉挛和神经性疼痛可诱导急性且持续时间较短的有益效果,但迄今为止证据仍非常初步,因此需要设计完善的临床试验。本文是名为“脊髓损伤”特刊的一部分。